WEKO3
アイテム
Carbon Ion Radiotherapy for Skull base and Paracervical Tumors
https://repo.qst.go.jp/records/63204
https://repo.qst.go.jp/records/63204a0894ef6-be3d-4666-a3df-00a949441bf9
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2009-08-20 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy for Skull base and Paracervical Tumors | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Hasegawa, Azusa
× Hasegawa, Azusa× Mizoe, Junetsu× Jingu, Keiichi× Bessho, Hiroki× Kamada, Tadashi× Tsujii, Hirohiko× 長谷川 安都佐× 溝江 純悦× 神宮 啓一× 別所 央城× 鎌田 正× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | To estimate the toxicity and efficacy of the clinical trials for patients with skull base and paracervical tumors treated with carbon ion radiotherapy. A phase I/II dose escalation study for skull base and paracervical tumor was initiated in April 1997. The phase I/II dose escalation trial was performed up to the fourth-stage dose level. From April 2004, a phase II clinical trial was initiated under the Highly Advanced Medical Technology scheme with an irradiation schedule of 60.8 GyE in 16 fractions over four weeks. At the time of analysis, there was no evidence of any serious acute or late reactions in skull base and paracervical tumors. For skull base and paracervical tumor, the carbon ion dose in excess of 57.6 GyE improves local control. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | NIRS-IMP Joint Symposium on Carbon Ion Therapy | |||||
発表年月日 | ||||||
日付 | 2009-08-15 | |||||
日付タイプ | Issued |